Reproductive Health Supplies Pricing in Nepal and Nicaragua
Equity, Availability and Affordability
Availability of essential RH medicine is low in both Nicaragua and Nepal.
Steps need to be taken to increase availability of essential RH products across sectors.
Product margins in Nepal (profits, distribution, taxes) are leading to high retail costs of essential RH medicines that many cannot afford.
Drug control authorities should enforce existing regulations governing allowable margins.
Public-sector and NGO programs should promote good-quality, low priced generic products.
Expectations of commercial-sector supply of RH medicines must be tempered with data on affordability.
Similar research is needed in additional countries to identify trends and inform planning and decision-making.